Related Experiment Video
Updated: Aug 11, 2026

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
Published on: August 24, 2015
Riboflavin deficiency in infants and children with heart disease
Insights
Children with cardiac disease show a higher prevalence of riboflavin deficiency compared to healthy peers. This highlights potential nutritional risks in pediatric heart patients.
Area of Science:
- Pediatric Cardiology
- Nutritional Biochemistry
- Public Health
Background:
- Riboflavin (vitamin B2) deficiency can impact overall health.
- Assessing nutritional status is crucial in vulnerable pediatric populations.
- Cardiac conditions may influence nutrient metabolism and requirements.
Purpose of the Study:
- To determine the prevalence of riboflavin deficiency in infants and children with cardiac disease.
- To compare this prevalence against a control group of similar socioeconomic status.
- To investigate the association between cardiac disease severity and riboflavin status.
Main Methods:
- Randomized selection of 31 infants and children with cardiac disease.
- Utilized erythrocyte glutathione reductase activity (EGRAC) to assess riboflavin status.
- Compared findings with a control group of comparable socioeconomic status.
Main Results:
- Eleven out of 31 children with cardiac disease exhibited riboflavin deficiency.
- This prevalence was significantly higher than in the control group.
- Deficiency was observed in both congenital and acquired heart disease, with a trend towards higher rates in congestive heart failure.
Conclusions:
- Riboflavin deficiency is more prevalent in pediatric patients with cardiac disease.
- Nutritional deficiencies may be underestimated in children with heart conditions.
- Screening for vitamin deficiencies should be considered in this patient group.
Abstract:
Thirty-one infants and children with cardiac disease were randomly selected to determine whether riboflavin deficiency is more prevalent among those with cardiac disease than among a group of comparable socioeconomic status without cardiac disease. Riboflavin studies were initiated since it is a representative member of the B complex and a specific and sensitive biochemical method is available to detect deficiency of this vitamin. The method involves the determination of the degree of saturation of erythrocyte glutathione reductase. Twenty-seven of the subjects had congenital heart disease and four had rheumatic heart disease. Eleven of the 31 had evidence of riboflavin deficiency, a significantly higher prevalence than among the group without cardiac disease. The deficiency existed among those with congenital and acquired cardiac disease. There was a greater tendency for the vitamin deficiency to occur among those with congestive heart failure. These studies indicate that nutritional deficiencies may be more prevalent among infants and children with cardiac disease than was previously thought.
Related Concept Videos
Vitamins
Inborn Errors of Metabolism
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease IV: Nursing Management
Respiratory Syncytial Virus Disease

